CE1 COST-EFFECTIVENESS OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING- A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY
Abstract
Authors
L Yang T Christensen J White F Sun